Regenexx for Business Overview Webinar for Cobbs Allen Clients
Why Join Us?
Orthopedic diseases cost $980 billion annually and typically makeup 20% of health plan spending. Regenexx has created a new medical specialty, Interventional Orthopedics. Using precise image-guided injections of orthobiologics, this treatment replaces the need for up to 70% of elective orthopedic surgeries and saves self-funded plans up to 70% compared to individual orthopedic surgeries.
During this 45 min. webinar, Jason Hellickson, of Regenexx Corporate, will join us in hosting a webinar for Cobbs Allen Clients that walks through the Regenexx cost-savings program for self-funded employers. Key learning objectives are outlined below.
- Understand the current state of musculoskeletal care and the costs involved.
- Distinguish between orthopedic surgery and interventional orthopedics.
- Identify the key issues a fiduciary must consider when deciding on adding an intervention to a health plan.
- Learn about the communication strategies that help create employee engagement.